BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2023 7:57:45 AM | Browse: 340 | Download: 1309
 |
Received |
|
2023-04-27 16:01 |
|
Peer-Review Started |
|
2023-04-27 16:04 |
|
First Decision by Editorial Office Director |
|
2023-05-08 03:32 |
|
Return for Revision |
|
2023-05-08 03:32 |
|
Revised |
|
2023-05-19 12:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-06-26 02:56 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-06-26 07:17 |
|
Articles in Press |
|
2023-06-26 07:17 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-07-05 02:01 |
|
Publish the Manuscript Online |
|
2023-07-12 07:57 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Genetics & Heredity |
| Manuscript Type |
Case Report |
| Article Title |
Antithrombin III deficiency in a patient with recurrent venous thromboembolism: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jia-Qing Luo, Shuai-Shuai Mao, Jin-Yi Chen, Xue-Ying Ke, Yue-Feng Zhu, Wei Huang, Hai-Ming Sun and Zhen-Jie Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Natural Science Foundation of China |
81670433 and 81970398 |
| the Project of Zhejiang Medical Young Talents (2017) |
|
| Zhejiang Medical and Health Science and Technology Project |
2020RC014 |
| the Natural Science Foundation of Zhejiang Province |
LR22H020002 |
|
| Corresponding Author |
Hai-Ming Sun, MD, Chief Physician, Department of Vascular Surgery, Changxing People's Hospital, No. 66 Taihu Middle Road, Changxing 313100, Zhejiang Province, China. sun76543212023@163.com |
| Key Words |
Antithrombin; Venous thrombosis; SERPINC1; Single nucleotide variant; Anticoagulant therapy; Case report |
| Core Tip |
Hereditary thrombophilia can be attributed to mutations in genes such as PROS, PROC, SERPINC1, and F5. Compared to mutations in other genes, mutations of SERPINC1 consistently lead to a more pronounced thrombophilia. Patients with this type of mutation are often advised to take warfarin as a therapeutic measure. However, evidence on the efficacy of direct oral anticoagulants is inadequate. Following identification of the SERPINC1 mutation, our patient was advised to take Rivaroxaban for 5 years to prevent the possibility of thrombus recurrence. This report may supply proof of the efficacy of direct oral anticoagulants in individuals suffering from hereditary thrombophilia. |
| Publish Date |
2023-07-12 07:57 |
| Citation |
Luo JQ, Mao SS, Chen JY, Ke XY, Zhu YF, Huang W, Sun HM, Liu ZJ. Antithrombin III deficiency in a patient with recurrent venous thromboembolism: A case report. World J Clin Cases 2023; 11(20): 4956-4960 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i20/4956.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i20.4956 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
